1. SELL CIT Group, Inc. (CIT) @ 1.28. — 2009-Oct-02 10:30:28: Closeout position. Check BTD Today’s Action page to verify, if necessary. 2. ( CHB) Champion Enterprises Inc. – shown as being liquidated under “UPDATE – PARTIAL LIQUIDATION OF PORTFOLIO,” dated 10/02/09. ERROR. STILL RETAIN POSITION. 3. (F) Ford Motor Company – [...]
BUY CHB @ 0.43 -– 2009-Oct-02 10:36:17: Champion Enterprises, Inc., together with its subsidiaries, produces and sells factory-built housing in the United States and western Canada. It also produces steel-framed modular buildings in the United Kingdom for use as prisons, military accommodations, hotels, residential units, and other commercial applications. The company also specializes in the [...]
PARTIAL LIQUIDATION OF PORTFOLIO
-
22-Sep-09
1.56
1,000
1530.000000$1,530.00
Amcore Financial, Inc.
AMFI
1.53
0.00
0.00%
-
22-Sep-09
0.97
1,000
1030.000000$1,030.00
BLOCKBUSTER INC
BBI
1.03
0.00
0.00%
-
22-Sep-09
1.88
1,000
1800.000000$1,800.00
BIOHEART, INC.
BHRT.OB
1.80
0.00
0.00%
-
-
0.50
2,000
840.000000$840.00
CHAMPION ENTERPRISES
CHB
0.42
0.00
0.00%
-
23-Sep-09
2.96
1,000
2340.000000$2,340.00
CENTRAL PACIFIC FNCL
CPF
2.34
0.00
0.00%
-
10-Jul-09
1.43
1,000
6300.000000$6,300.00
DANA HOLDING CP
DAN
6.30
0.00
0.00%
-
23-Sep-09
1.70
1,000
720.000000$720.00
DAIS ANALYTIC CORP
DLYT.OB
0.72
0.00
0.00%
-
-
2.51
2,000
13940.000000$13,940.00
FORD MOTOR CO
F
6.97
0.00
0.00%
-
22-Sep-09
1.81
1,000
1450.000000$1,450.00
Genetic Technologies Ltd
GENE
1.45
0.00
0.00%
-
25-Feb-09
2.39
1,000
8570.000000$8,570.00
HUNTSMAN CORPORATION
HUN
8.57
0.00
0.00%
-
22-Sep-09
2.11
1,000
2070.000000$2,070.00
Linktone Ltd.
LTON
2.07
0.00
0.00%
-
22-Sep-09
1.41
1,000
1400.000000$1,400.00
NEOPROBE CORPORATION
NEOP.OB
1.40
0.00
0.00%
-
22-Sep-09
1.36
1,000
1350.000000$1,350.00
Quantum Fuel Systems Technologi
QTWW
1.35
0.00
0.00%
-
7-Apr-09
3.99
1,000
7760.000000$7,760.00
RUBY TUESDAY INC
RT
7.76
0.00
0.00%
-
22-Sep-09
0.68
1,000
596.599976$596.60
Sirius [...]
SELL ONCY @ 3.40. . . Take profit – DAY TRADER – 2009-Oct-02 05:36:05:
ONCY announces that it has reached an agreement with the U.S. Food and Drug Administration under the Special Protocol Assessment process for the design of a Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head [...]
BUY ONCY @ 2.94. – 2009-Oct-02 05:00:58: Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (“Oncolytics”) (TSX:ONC, NASDAQ:ONCY), will host a conference call and webcast on Friday, October 2, 2009 at 6:30 a.m. MT (8:30 a.m. ET) to update investors on the Company’s Phase 3 program for REOLYSIN®. Expect positive results. No [...]
